X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2246) 2246
Publication (180) 180
Book Chapter (21) 21
Book Review (10) 10
Dissertation (10) 10
Conference Proceeding (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1409) 1409
cd30 (990) 990
index medicus (759) 759
male (694) 694
female (641) 641
adult (523) 523
middle aged (495) 495
expression (440) 440
cd30 antigen (426) 426
oncology (382) 382
pathology (366) 366
aged (363) 363
immunology (361) 361
lymphomas (345) 345
immunohistochemistry (339) 339
hematology (314) 314
lymphoma (304) 304
disease (270) 270
animals (264) 264
dermatology (248) 248
ki-1 antigen - metabolism (247) 247
adolescent (233) 233
soluble cd30 (218) 218
anaplastic large cell lymphoma (214) 214
reed-sternberg cells (209) 209
hodgkins-disease (205) 205
t cells (201) 201
cancer (199) 199
ki-1 antigen - immunology (197) 197
diagnosis (189) 189
lymphocytes (184) 184
mice (183) 183
prognosis (181) 181
skin neoplasms - pathology (171) 171
cd30 ligand (164) 164
hemic and lymphatic diseases (164) 164
t-cells (160) 160
brentuximab vedotin (158) 158
transplantation (157) 157
child (156) 156
ki-1 antigen - blood (156) 156
ki-1 antigen - analysis (155) 155
cytokines (153) 153
lymphoma, large-cell, anaplastic - pathology (153) 153
hodgkin's disease (151) 151
lymphomatoid papulosis (145) 145
skin (142) 142
classification (139) 139
diagnosis, differential (136) 136
chemotherapy (135) 135
receptor (135) 135
aged, 80 and over (133) 133
treatment outcome (126) 126
hodgkin disease - pathology (125) 125
activation (123) 123
analysis (123) 123
flow cytometry (117) 117
tumors (117) 117
apoptosis (114) 114
lymphocytes t (114) 114
cell biology (112) 112
immunophenotyping (112) 112
biopsy (111) 111
immune system diseases (111) 111
immunotherapy (111) 111
t-cell lymphoma (111) 111
large-cell lymphoma (110) 110
lymphoproliferative disorders (110) 110
non-hodgkin's lymphomas (110) 110
surgery (110) 110
antigen (108) 108
hodgkin lymphoma (107) 107
cd30 expression (105) 105
anaplastic large-cell lymphoma (101) 101
care and treatment (99) 99
non-hodgkins-lymphoma (97) 97
ki-1 antigen - genetics (96) 96
mycosis fungoides (92) 92
young adult (91) 91
child, preschool (90) 90
retrospective studies (86) 86
health aspects (85) 85
research (85) 85
gene expression (80) 80
hodgkin disease - drug therapy (80) 80
medicine, research & experimental (80) 80
t-lymphocytes - immunology (79) 79
epstein-barr-virus (78) 78
medicine & public health (78) 78
article (77) 77
phase-ii (77) 77
immunoconjugates - therapeutic use (76) 76
lymphocytes b (76) 76
cell line, tumor (75) 75
hodgkin disease - immunology (75) 75
antineoplastic agents - therapeutic use (74) 74
biochemistry & molecular biology (74) 74
ki-1 antigen (74) 74
lymphoma, large b-cell, diffuse - pathology (74) 74
signal transduction (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2128) 2128
Korean (39) 39
German (37) 37
French (15) 15
Japanese (11) 11
Polish (10) 10
Russian (10) 10
Spanish (10) 10
Chinese (8) 8
Italian (4) 4
Dutch (2) 2
Czech (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue S2, pp. 281 - 283
Journal Article
Journal of Autoimmunity, ISSN 0896-8411, 2014, Volume 57, pp. 14 - 23
Abstract The CD30 ligand (CD30L)/CD30 axis plays a critical role in Th1 and Th17 cell differentiation. However, the role in the pathogenesis of central nervous... 
Allergy and Immunology | EAE | CD30 | CD30 ligand | CD30-Ig | ACTIVATION | EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS | RECEPTOR | KAPPA-B | INDUCTION | IMMUNOLOGY | CD30L/CD30 | TUMOR-NECROSIS-FACTOR | T-CELL RESPONSES | MICE | EXPRESSION | Myelin-Oligodendrocyte Glycoprotein - immunology | Cell Proliferation | Encephalomyelitis, Autoimmune, Experimental - metabolism | Autoimmunity - genetics | Encephalomyelitis, Autoimmune, Experimental - immunology | Ki-1 Antigen - immunology | Adoptive Transfer | Th1 Cells - immunology | CD4-Positive T-Lymphocytes - immunology | Th1 Cells - metabolism | Cell Differentiation - genetics | Signal Transduction - immunology | Flow Cytometry | Th17 Cells - metabolism | Autoimmunity - immunology | Bone Marrow Cells - immunology | Peptide Fragments - immunology | Encephalomyelitis, Autoimmune, Experimental - genetics | Cytokines - immunology | CD30 Ligand - immunology | Cytokines - metabolism | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Signal Transduction - genetics | Ki-1 Antigen - metabolism | Mice, Knockout | Cell Differentiation - immunology | Animals | CD30 Ligand - metabolism | CD30 Ligand - genetics | Th17 Cells - immunology | Bone Marrow Cells - metabolism | Animal experimentation | Autoimmunity | Medical colleges | Central nervous system | T cells | Cell differentiation | Health aspects
Journal Article
Journal Article
Histopathology, ISSN 0309-0167, 10/2019, Volume 75, Issue 4, pp. 602 - 605
Follicular lymphoma is the most common indolent B cell lymphoma, accounting for 20% of all non-Hodgkin lymphomas. Transformation of follicular lymphoma to a... 
CD30+ lymphoma | anaplastic large cell lymphoma | follicular lymphoma | transformation | Lymphocytes B | CD30 antigen | B-cell lymphoma
Journal Article
Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 09/2017, Volume 15, Issue 9, p. 951
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2018, Volume 181, Issue 6, pp. 752 - 759
Summary Primary cutaneous CD30+ T cell lymphoproliferative disorders (PCLPD), the second most common type of primary cutaneous T cell lymphomas, accounts for... 
socioeconomic factors | primary cutaneous CD30+ T‐cell lymphoproliferative disorders | ethnicity | prognosis | NCDB | primary cutaneous CD30 | T-cell lymphoproliferative disorders | SURVIVAL | ONSET MYCOSIS-FUNGOIDES | LYMPHOMATOID PAPULOSIS | WHO-EORTC CLASSIFICATION | FEATURES | ORGANIZATION | primary cutaneous CD30(+) T-cell lymphoproliferative disorders | SKIN | HEMATOLOGY | United States - epidemiology | Age Factors | Follow-Up Studies | Humans | Middle Aged | Male | Lymphoproliferative Disorders - therapy | Socioeconomic Factors | Lymphoproliferative Disorders - ethnology | Skin Neoplasms - mortality | Neoplasm Proteins | Head and Neck Neoplasms - ethnology | Adult | Female | Retrospective Studies | Databases, Factual | Skin Neoplasms - therapy | T-Lymphocytes | United States - ethnology | Head and Neck Neoplasms - therapy | Skin Neoplasms - ethnology | Survival Rate | Ki-1 Antigen | Disease-Free Survival | Lymphoproliferative Disorders - mortality | Sex Factors | Aged | Head and Neck Neoplasms - mortality | Chemotherapy | Databases | Analysis | African Americans | Rankings | Non-Hodgkin's lymphomas | T cells | Cancer | Disorders | Economic factors | Lymphocytes T | Social factors | Multivariate analysis | Socioeconomics | Data bases | Rank tests | Matching | Demographics | CD30 antigen | Lymphocytes | Head and neck | Medical treatment | Immunoproliferative diseases | Socio-economic aspects | Regression analysis | Cultural differences | Minority & ethnic groups | Patients | Survival | Lymphoma | Ethnicity | Socioeconomic factors | Medical prognosis
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 04/2017, Volume 15, Issue 4, pp. 390 - 394
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 04/2018, Volume 8, p. 139
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 04/2018, Volume 45, Issue 4, pp. 296 - 298
Cutaneous intravascular CD30+ pseudolymphoma is an uncommon incidental finding that may mimic intravascular or angiotropic lymphoma. We describe a 78‐year‐old... 
CD30+ pseudolymphoma | dermatopathology | keratoacanthoma | CELL LYMPHOMA | CD30+pseudolymphoma | PROLIFERATION | PATHOLOGY | DERMATOLOGY | T cells | Keratoacanthoma | CD30 antigen | Biopsy | Lymphocytes | Cheek | Immunoproliferative diseases | Lymphocytes T | Lymphomas | CD3 antigen | Lymphoma | CD45 antigen
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 04/2013, Volume 139, Issue 4, pp. 491 - 514
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2019, Volume 186, Issue 1, pp. 159 - 162
Fig S2. Example of CD30 expression in Hodgkin cells (red) in lymph nodes involved by CHL in a patient before (A) and after treatment with Brentuximab Vedotin... 
CD30 | anaplastic large cell lymphoma | Hodgkin lymphoma | brentuximab vedotin | HEMATOLOGY | Medicine, Experimental | Medical research | Care and treatment | Lymphomas | Brentuximab vedotin | CD30 antigen
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 11/2019, Volume 46, Issue 11, pp. 823 - 829
Aims Brentuximab vedotin is a monoclonal anti‐CD30 antibody‐drug conjugate that has been used to treat a variety of CD30+ neoplasms. The phenomenon of antigen... 
anaplastic large cell lymphoma | loss of CD30 | brentuximab | CD30+ cutaneous T‐cell lymphoma | mycosis fungoides | Immunohistochemistry | Antigens | CD30 antigen | Tumor cells | CD20 antigen | Rituximab | Lymphomas | Anaplastic large-cell lymphoma | Tumors
Journal Article
Journal Article
Journal Article